Neuronal Intranuclear Inclusion Disease Without Polyglutamine Inclusions in a Child

Neuronal intranuclear inclusion disease (NIID) is a rare and heterogeneous group of slowly progressive neurodegenerative disorders characterized by the widespread presence of eosinophilic neuronal intranuclear inclusions (NII) accompanied by a more restricted pattern of neuronal loss. We report here the pathologic findings in a 13-year-old boy who died after a 6-year clinical history of progressive ataxia, extrapyramidal manifestations, and lower motor neuron abnormalities. Histological evaluation of the brain revealed widespread NII in most neurons. Marked loss of cerebellar Purkinje cells and neurons in the dentate nucleus, red nucleus, and spinal cord anterior horns was accompanied by a modest astrocytosis. Because of the abundance of NII and the absence of a relationship between NII and neuronal loss or microglial activation, we conclude that loss of cerebellar, brainstem, and spinal cord neurons reflects selective neuronal vulnerability. NII were immunoreactive for ubiquitin, glucocorticoid receptor, and SUMO-1, a small, ubiquitin-like protein purportedly involved in protein transport and gene transcription. NII were non-reactive for polyglutamine (1C2), TATA binding protein, promyelocytic leukemia protein, heat shock protein 90, tau, alpha-synuclein, neurofilament, and beta amyloid. The moderate ubiquitin and strong SUMO-1 staining of NII in juvenile cases is the reverse of the pattern noted in adult diseases, suggesting the two age groups are pathogenically distinct. We suggest that juvenile NIID is a spinocerebellar brainstem ataxic disease possibly related to an abnormality in SUMOylation.

[1]  John Q Trojanowski,et al.  Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease , 1998, The Lancet.

[2]  Ronald Wetzel,et al.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.

[3]  D W Dickson,et al.  Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. , 1995, Clinical neuropathology.

[4]  T. Uchihara,et al.  Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions , 2000, Acta Neuropathologica.

[5]  J. Sung,et al.  An Unusual Degenerative Disorder of Neurons Associated with a Novel Intranuclear Hyaline Inclusion (Neuronal Intranuclear Hyaline Inclusion Disease): A Clinicopathological Study of a Case , 1980, Journal of neuropathology and experimental neurology.

[6]  P. Pandolfi,et al.  SUMO Modification of Huntingtin and Huntington's Disease Pathology , 2004, Science.

[7]  C. Duyckaerts,et al.  PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases , 2003, Neurobiology of Disease.

[8]  I. Janota WIDESPREAD INTRANUCLEAR NEURONAL CORPUSCLES (MARINESCO BODIES) ASSOCIATED WITH A FAMILIAL SPINAL DEGENERATION WITH CRANIAL AND PERIPHERAL NERVE INVOLVEMENT , 1979, Neuropathology and applied neurobiology.

[9]  J. Palo,et al.  Neuronal intranuclear inclusion disease in identical twins , 1984, Annals of neurology.

[10]  M. Popović,et al.  Cardiomyopathy and myocyte intranuclear inclusions in neuronal intranuclear inclusion disease: a case report. , 1991, Human pathology.

[11]  Jean Marx,et al.  SUMO Wrestles Its Way to Prominence in the Cell , 2005, Science.

[12]  K. Fischbeck,et al.  Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease. , 1999, Annals of neurology.

[13]  H. Yasuda,et al.  SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death , 2002, Neuroreport.

[14]  G. Guazzi,et al.  Neuronal intranuclear inclusion disease: neuropathologic study of a case , 1998, Brain and Development.

[15]  J. Gilbert,et al.  Multiple system atrophy with neuronal intranuclear hyaline inclusions , 1981, Acta Neuropathologica.

[16]  Hitoshi Takahashi,et al.  Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells , 2001, Brain Research.

[17]  E. Haan,et al.  SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease , 2003, Experimental Neurology.

[18]  R. Edis,et al.  Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions , 1998, Journal of the Neurological Sciences.

[19]  N. Funata,et al.  Recruitment of Nonexpanded Polyglutamine Proteins to Intranuclear Aggregates in Neuronal Intranuclear Hyaline Inclusion Disease , 2001, Journal of neuropathology and experimental neurology.

[20]  S. Ludwin,et al.  Clinicopathological Studies of Some Non-Alzheimer Dementing Diseases , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  Junko Takahashi-Fujigasaki,et al.  Neuronal intranuclear hyaline inclusion disease , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[22]  Kiyoshi Iwabuchi,et al.  Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias – triple-labeling immunofluorescence study , 2001, Acta Neuropathologica.

[23]  S. Rossi,et al.  Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration. , 2002, Archives of neurology.

[24]  E. Mengual,et al.  Immunohistochemical Distribution and Electron Microscopic Subcellular Localization of the Proteasome in the Rat CNS , 1996, The Journal of Neuroscience.